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Abstract
Background Although subthreshold conditions are asso-
ciated with impairment in numerous disorders, research on
obsessive–compulsive disorder (OCD) below the diagnos-
tic threshold of DSM-IV in the general population is
limited.
Purpose To estimate the DSM-IV 12-month prevalence,
comorbidity and impairment of OCD, subthreshold OCD
(i.e., fulfilling some but not all core DSM-IV criteria), and
obsessive–compulsive symptoms (OCS) (i.e., endorsement
of OCS without fulfilling any core DSM-IV criteria) in a
general population sample.
Methods Data from the German National Health Inter-
view and Examination Survey–Mental Health Supplement
(N = 4181, age 18–65 years), based on the standardized
diagnostic Munich Composite International Diagnostic
Interview.
Results The 12-month prevalence of OCD was 0.7%,
subthreshold OCD was 4.5%, and OCS was 8.3%. Subjects
in all three groups showed higher comorbidity (odds ratios
[ORs] C 3.3), compared to those without OCS. The OCD,
subthreshold OCD and OCS were all associated with
increased odds of substance abuse/dependence-, mood-,
anxiety- and somatoform disorders, with especially strong
associations with possible psychotic disorder (ORs C 4.1)
and bipolar disorders (ORs C 4.7). Participants in all three
groups showed higher impairment (ORs C 3.1) and health-
care utilization (ORs C 2.4), compared to those without
OCS, even after controlling for covariates.
Conclusions Individuals with subthreshold OCD and
OCS, not currently captured by DSM-IV OCD criteria,
nevertheless show substantial comorbidity, impairment and
health-care utilization. This should be taken into account in
future conceptualization and classification of OCD and
clinical care.
Keywords Obsessive–compulsive disorder  Obsessive–
compulsive symptoms  Epidemiology  Mental disorder 
Cross-sectional survey
Introduction
Obsessive–compulsive disorder (OCD) is one of the ten
most debilitating conditions among all physical and mental
diseases worldwide [38]. According to the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV) [1] the core clinical features of OCD are
obsessions and/or compulsions. Obsessions are persistent
thoughts, impulses, or images that are experienced as
intrusive and inappropriate and cause anxiety or distress.
Compulsions include repetitive behaviors or mental acts
performed in response to obsessions and are aimed at
preventing or reducing the distress or some dreaded out-
come. Those afflicted with OCD often have difficulty
suppressing such thoughts or behaviors, although they
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usually recognize that the obsessions or compulsions are
unreasonable and excessive [1].
Recent epidemiological and clinical population studies
suggest that subthreshold mental disorders, which by def-
inition do not fulfill all of the required criteria of a given
diagnosis, are common [26, 34, 35, 49]. These subthreshold
mental conditions are not benign or simply diagnostic
artifacts. Instead, individuals who endorse subthreshold
conditions are likely to suffer from substantial comorbidity
and impairment [34, 49]. Despite mounting evidence of the
pernicious effects of subclinical conditions in general, the
understanding of such issues in OCD is limited [2]. To
date, only three studies (see Table 1) have examined
impairment and health care utilization in relation to sub-
threshold conditions of OCD, defined as fulfilling at least
one but not all core DSM-III-R/IV criteria [9, 23] or
defined as the presence of obsessive–compulsive symptoms
(OCS) according to DSM-IV as well as moderate distress
[2]. These studies have found that the 12-month prevalence
of subthreshold OCD was more frequent (0.6–4.9%) [3, 9,
22, 53] than that of threshold OCD (0.3–3.0%) [2, 7, 9, 23,
31, 37, 50, 53, 57] in the general population and that the
subthreshold conditions are strongly associated with more
comorbidity, poorer functioning at work or in social
activities and a greater use of health-care services [2, 3, 9,
22, 23].
It remains an open question whether these negative
effects are associated with the presence of any subthreshold
OCS or if a certain critical level of symptomatology must be
achieved before the negative affects occur. Extant studies
have documented that the phenomenon of OCS without
further sub-clinical features does indeed exist and with
substantial prevalence rates in the general population.
Nestadt and colleagues [40] estimated the 1-month preva-
lence rate of OCS at 1.5% in the Eastern Baltimore Mental
Health Survey sample. This rather low rate may be based on
the fact that the questions on OCS in the diagnostic inter-
view applied in this study covered only three potential
obsessions and compulsions, and, moreover, the features
were only counted as OCS if they did ‘occur against
Table 1 Previous epidemiological studies estimating impairment and health care use in subjects with subthreshold OCD
Study Sample Instrument Interviewer Prevalence rates Definition of subthreshold
OCD
Transitions in alcohol
consumption and smoking
Grabe et al. [23]
4,075
(Age
18–64)
DSM-IV; DIA-X/
M-CIDI
Lay Lifetime: OCD
0.5%
Subthreshold
OCD 2%
12-Month: OCD
0.39%
Subthreshold
OCD 1.6%
The presence of OC symptoms
of DSM-IVa ? at least one
criterion of the DSM-IV
criteria A, B, C for OCD is
affirmedb
The Zurich study
Angst et al. [2]
591
(Age
20–40)
DSM-IV; SPIKE Psychiatrist/clinical
psychologist
Lifetime: OCD
3.5%
Subthreshold
OCD 8.7%
The presence of OC symptoms
of DSM-IVa ? moderate
distress (29–49 on the
analogue scale 0–100)
The Netherlands Mental Health
Survey and Incidence Study
(NEMESIS)
de Bruijn et al. [9]
7,076
(Age
18–64)
DSM-III-R; CIDI Lay Lifetime: OCD
0.9%
Subthreshold
OCD 4.9%
The presence of OC symptoms
of DSM-III-Ra ? at least
criterion A is affirmedc
CIDI The Composite International Diagnostic Interview; DIA-X/M-CIDI The Munich Composite International Diagnostic Interview; DSM-III-R
Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised; DSM-IV Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition; OC obsessive–compulsive; OCD obsessive–compulsive disorder; SPIKE The Structured Psychopathological Interview and
Rating of the Social Consequences for Epidemiology
a For example, thoughts of violence, contamination, doubt, or behaviors such as washing, checking, ordering, and hoarding
b The DSM-IV OCD criteria: criterion A (Obsessions: The symptoms are recognized as a product of the own mind, are recurrent and persistent
and not simply excessive worries about real life problems; the person attempts to ignore, suppress or neutralize them. Compulsions: Repetitive
behaviors or mental acts in response to an obsession or according to rules, which are aimed at preventing or reducing distress or dreaded events
(even though this response is excessive or connected to the obsession in an unrealistic way), criterion B (The person recognizes the symptoms are
excessive or unreasonable), criterion C (The symptoms are time consuming––at least 1 h per a day––or cause a substantial impairment or
distress)
c The DSM-III-R OCD criterion A (The symptoms are repetitive or recurrent and the person recognizes the symptoms are excessive or
unreasonable)
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conscious resistance’. In contrast, the 1-month prevalence
of obsessions or compulsions in a Canadian community
sample was 26.2 and 22.2%, respectively [53]. In the Zurich
study [14], 29.8% of young adult subjects endorsed OCS at
least once during the longitudinal study period of 10 years.
Likewise, the lifetime prevalence of OCS was 28.2% in the
National Comorbidity Survey Replication (NCSR) sample
[50]. The clinical importance of OCS without further sub-
clinical features (i.e. none of the core DSM-III-R/IV criteria
is fullfilled) remains largely unknown despite documenta-
tion of such substantial prevalence rates. Two studies by
Fullana and colleagues [20, 21] reported that the presence of
OCS dimensions (i.e., contamination, symmetry/ordering,
harm/checking, etc.) was associated with an increased risk
of most mental disorders other than OCD. Nevertheless, to
our knowledge, no epidemiological study has examined the
differences in sociodemographic risk indicators, comor-
bidity and impairment across the various degrees of
symptomatology (i.e., full-blown OCD, subthreshold OCD
and OCS) using DSM-IV criteria for OCD in a general
population sample in the same study.
In the current paper, we address these open issues using
data from the German Health Interview and Examination
Survey and its Mental Health Supplement. Extending the
prevalence findings reported by Jacobi et al. [29], the
purposes of this study are to determine the 12-month
prevalence of DSM-IV-defined OCD, subthreshold OCD
(i.e., fulfilling at least one but not all core DSM-IV criteria)
and OCS (i.e., endorsement of at least one obsessive or
compulsive symptom without fulfilling any of the core
DSM-IV criteria) and to examine how these varying levels
are associated with sociodemographic characteristics,
comorbid other mental disorders, current impairment, and
health-care utilization in the general population.
Materials and methods
Design and sample
Data were taken from the German Health Interview and
Examination Survey, Mental Health Supplement (GHS-
MHS). The GHS-MHS assessed a subsample of the
German Health Survey (GHS), the first nationwide cross-
sectional study in Germany for medical and social
assessments, commissioned by the German Ministry of
Science, Research and Education and the Robert Koch
Institute and authorized by the relevant institutional review
board and ethics committee. The GHS (core study) was
designed to collect data on somatic disorders, impairments,
healthcare utilization and sociodemographic characteristics
in a representative sample of 7,124 subjects aged 18–79
living in Germany in 1997 (response rate: 61.4%). The
sample was drawn from population registries of 113
communities throughout Germany with 130 sampling sites.
For financial and logistical reasons the data for mental
disorders were gathered using a two-stage design. The first
stage entailed the administration of a 12-item screening
questionnaire for mental disorders (CID-S) [60] at the end
of the medical examination of the core study (GHS). The
second stage involved the separate administration of the
computer-assisted version of the Munich Composite
International Diagnostic Interview (DIA-X/M-CIDI) to all
core survey respondents who screened positive for a mental
disorder and to a random sample of 50% who screened
negative. This second stage forms the GHS-MHS and
covers a subsample of the GHS (N = 4181; aged 18–65;
conditional response rate: 87.6%). Due to the resulting
oversampling of positive screenings, data were weighted in
later analyses. Written informed consent was obtained for
the GHS and the GHS-MHS. Detailed description of aims,
design, and methods of the GHS has been described else-
where [28].
Assessment
The diagnostic assessments were based on the DIA-X/M-
CIDI. The DIA-X/M-CIDI is a fully structured interview, a
modified version of the World Health Organization CIDI
(version 1.2; WHO, 1997), supplemented by questions to
cover DSM-IV and ICD-10 criteria. The DIA-X/M-CIDI
allows the assessment of symptoms, syndromes and diag-
noses of mental disorders along with information about
onset, duration, and clinical/psychological severity. The
clinical interviewers were trained psychologists and phy-
sicians. Diagnostic findings reported in this paper were
obtained using the DIA-X/M-CIDI diagnostic algorithms
[44]. All subsequent analyses were performed for
12-month criteria. The test–retest reliability of the full
DIA-X/M-CIDI was good with kappa values ranging
between 0.56 and 0.81 [61]. For the OCD, the test–retest
reliability with an average time interval of 38 days between
interviews, investigating in a general population sample of
60 subjects was found to be excellent (j = 0.81) [61]. The
validity of the DIA-X/M-CIDI OCD diagnoses compared
to diagnoses from independent treating physicians in a
sample of 68 randomly chosen patients was also excellent
(j = 0.91). The sensitivity was 100%, while the specificity
was 98.4% [47].
Assessment of OCD
The DIA-X/M-CIDI-OCD module consists of two parts:
one for the assessment of obsessions, and one for the
assessment of compulsions. The obsession section begins
with a stem question in order to scan a wide range of
Soc Psychiatry Psychiatr Epidemiol (2012) 47:339–349 341
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potential thoughts and cognitions presented in the form of a
symptom list (‘‘During the last 12 months, have you been
bothered by having certain unpleasant thoughts or images
like recurrent arbitrary thoughts, such as the idea that your
hands are dirty or have germs on them?’’ [yes or no]). The
rest of the obsession section is skipped entirely if the
respondent answers no. If respondents acknowledge at least
one item, they are subsequently asked for the mandatory
DSM-IV criteria before providing information on the age
of onset and last occurrence. In the subsequent section on
compulsions, three stem questions are again presented to
assess whether he or she had engaged in repetitive
behaviors (‘‘doing something like washing hands over and
over again’’ [yes or no] or ‘‘checking several times whether
the door is locked’’ [yes or no]) or mental acts (‘‘counting
something like tiles in a floor’’ [yes or no]). This second
part of the OCD section is also skipped when the respon-
dent answers no. Respondents, who acknowledge at least
one of these stem questions, are then asked for the
remaining mandatory criteria A (diagnostic details of
obsessions and compulsions), B (recognition that the
obsessions or compulsions are excessive or unreasonable),
and C (causes distress or dysfunction).
Based on the respondents’ responses from the DIA-X/
M-CIDI-OCD section, this paper splits the sample into four
mutually exclusive groups:
(a) OCD: the subject met full DSM-IV criteria A, B, and
C for OCD.
(b) Subthreshold OCD: The subject affirmed at least one
of the stem questions for obsessive or compulsive
symptoms, and fulfilled at least one of the DSM-IV
diagnostic criteria A, B or C, but not full DSM-IV
criteria.
(c) OCS: The subject affirmed at least one of the stem
questions for obsessive or compulsive symptoms, but
did not fulfill any of the DSM-IV criteria A, B or C.
(d) No OCS: the subject did not affirm any of the stem
questions for obsessions or compulsions.
Sociodemographic correlates
The following sociodemographic correlates of DSM-IV
OCD, subthreshold OCD and OCS were examined: gender,
age, marital status, working status, and social class. The
assessment of social class was based on the Winkler Index
[59]. The Winkler Index uses information about educa-
tional level, monthly net household income, and occupa-
tional position as indicators for social class. Each indicator
ranges from 1 (the lowest status) to 7 (the highest status).
The total index (Winkler Index) values can therefore range
between 3 and 21 points. Based on the total index values,
three social classes were defined: (1) low (from 3 to 8
points), (2) middle (from 9 to 14 points), and (3) high (from
15 to 21 points).
Associations between OCD and other mental disorders
The following DSM-IV mental disorders were used for
comorbidity analyses: any mental disorder due to general
medical conditions; substance use disorders (alcohol abuse/
dependence, nicotine dependence, illicit substance abuse/
dependence); possible psychotic disorder (In the DIA-X/
M-CIDI, possible psychotic disorder included the experi-
ence of psychotic symptoms of delusions or hallucinations
combined with speaking to a doctor about the symptoms);
mood disorders (major depressive disorder, dysthymia,
bipolar disorders); anxiety disorders (panic disorder with
and without agoraphobia, agoraphobia without panic dis-
order, social phobia, simple phobias, phobic disorder not
otherwise specified (NOS), generalized anxiety disorder);
somatoform disorders (somatization disorder, undifferen-
tiated somatoform disorder, somatic symptom index (SSI)
4/6, pain disorder, hypochondriasis); and eating disorders
(anorexia nervosa, atypical anorexia nervosa, bulimia
nervosa, atypical bulimia nervosa, for definition see
Table 3).
Impairment and health-care utilization
Current impairment was assessed by asking the respondent
whether he or she was completely or partially unable to
carry out daily activities (function at work, in school or in
family), because of psychological problems in the 4 weeks
before the interview took place [yes or no]. Health-care
utilization was evaluated by asking the respondent whether
he or she had ever received at least a minimal intervention
for any of his or her mental health conditions (i.e., ‘‘having
ever sought any kind of treatment because of psychological
problems or having been recommended by a doctor to seek
any psychological or psychiatric treatment’’ [yes or no]).
Statistical analyses
The data were weighted for age, gender, community dis-
tribution, and screening status in order to address different
sampling probabilities and systematic non-response [28].
Statistical analyses were calculated using the STATA
software package, version 10.0 [51], and the Huber-White
sandwich matrix was applied for robust estimates of con-
fidence intervals in case of weighted data [48]. Logistic
regression (odds ratio [OR] with 95% confidence intervals
[CI]) was used to examine associations between OCD,
subthreshold OCD, OCS and covariates (sociodemographic
characteristics, comorbid mental disorders, impairment,
and health-care utilization). Throughout the paper, a p value
342 Soc Psychiatry Psychiatr Epidemiol (2012) 47:339–349
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\0.05 was considered as statistically significant. All
comparisons were controlled for age and gender.
Results
12-month prevalence of OCD, subthreshold OCD
and OCS
The 12-month prevalence rate for OCD was 0.7% (95%
CI = 0.4–1.1; weighted number [Nw] = 30), for sub-
threshold OCD 4.5% (95% CI = 3.8–5.2; Nw = 188),
and for OCS 8.3% (95% CI = 7.4–9.2; Nw = 346). Thus,
in the total sample 13.5% (95% CI = 12.3–14.7%;
Nw = 564) of the 4,181 subjects reported having expe-
rienced at least one OC symptom in the last 12 months.
In the total sample, 86.5% (95% CI = 83.7–89.4;
Nw = 3,617) of the respondents reported no OCS during
the last 12 months.
Sociodemographic correlates
No associations were found between OCD and gender, age,
marital, employment status, and social class (Table 2). The
12-month prevalence rates of subthreshold OCD and OCS
were lower in the older age group (50–65 years) compared
to the younger age group (18–34 years) (subthreshold
OCD: OR = 0.4, 95% CI = 0.3–0.8; OCS: OR = 0.6,
95% CI = 0.4–0.9). The 12-month prevalence rates of
OCS were higher in the separated, divorced, or widowed
subjects group, when compared to those who were married
(OR = 1.6, 95% CI = 1.1–2.4). No socio-demographic
correlates were found for subthreshold OCD and OCS with
gender, employment status and social class.
Table 2 Sociodemographic correlates of OCD, subthreshold OCD and OCS (12-month prevalences if correlate present [weighted data])
OCD (n = 30) Subthreshold OCD (n = 188) OCS (n = 346)
% ORa 95% CI % ORa 95% CI % ORa 95% CI
Gender
Male 0.6 1.0 4.0 1.0 7.9 1.0
Female 0.9 1.6 (0.7–3.3) 5.0 1.2 (0.9–1.8) 8.7 1.1 (0.8–1.5)
Age
18–34 years 0.7 1.0 5.7 1.0 9.7 1.0
35–49 years 0.9 1.3 (0.5–2.9) 4.7 0.8 (0.5–1.2) 8.6 0.8 (0.6–1.2)
50–65 years 0.5 0.7 (0.3–1.8) 2.9 0.4* (0.3–0.8) 6.3 0.6* (0.4–0.9)
Marital status
Married 0.5 1.0 3.9 1.0 7.6 1.0
Single 0.9 1.7 (0.6–4.9) 6.5 1.4 (0.9–2.3) 8.5 0.8 (0.6–1.3)
Separated/divorced/widowed 1.4 2.5 (0.9–6.4) 4.1 1.0 (0.6–1.8) 11.7 1.6* (1.1–2.4)
Employment status
Fulltime 0.7 1.0 4.2 1.0 7.9 1.0
15–34 h/week 0.7 0.6 (0.1–3.2) 6.8 1.6 (0.9–3.0) 7.8 0.9 (0.6–1.7)
\15 h/week 0 – – 4.8 1.1 (0.5–2.6) 9.8 1.2 (0.6–2.5)
Retired 0.6 0.6 (0.1–2.4) 3.3 1.0 (0.4–2.3) 5.9 0.9 (0.5–1.7)
School/student 0.9 1.2 (0.3–4.4) 5.1 0.9 (0.5–2.0) 8.4 0.8 (0.5–1.5)
Unemployed 1.1 1.2 (0.3–5.2) 3.1 0.7 (0.3–1.7) 9.5 1.2 (0.8–2.1)
Homemaker 0.6 0.5 (0.1–2.1) 4.9 1.1 (0.6–2.2) 9.8 1.2 (0.8–2.0)
Social classb
Low 1.1 1.0 5.5 1.0 9.1 1.0
Middle 0.7 0.6 (0.2–1.5) 4.4 0.7 (0.5–1.2) 8.1 0.8 (0.6–1.2)
High 0.4 0.3 (0.1–1.2) 4.2 0.7 (0.4–1.3) 8.1 0.9 (0.6–1.4)
CI confidence intervals, OCD obsessive–compulsive disorder, OCS obsessive–compulsive symptoms, OR odds ratios from logistic regression
adjusted for age and gender
* p \ 0.05
a All three groups were compared with No OCS separately for logistic regression
b Based on ‘Index of social class’ (Winkler and Stolzenberg [59]) derived from information on education, income and occupational position.
Each indicator ranges from 1 (the lowest status) to 7 (the highest status). The total index values can take between 3 and 21 points. Threes social
classes were defined based on the total values: Low (from 3 to 8), Middle (from 9 to 14 points), and High (from 15 to 21 points)
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12-month comorbidity with other mental disorders
Higher rates of comorbidity were found for almost all of
the assessed DSM-IV mental disorders in subjects with
OCD, subthreshold OCD and OCS as compared to subjects
with No OCS (see Table 3). At least one mental disorder
other than OCD was assessed in 89.2% of the subjects with
OCD, 65.9% of the subjects with subthreshold OCD, and
61.2% of the subjects with OCS. It was seen that OCD,
subthreshold OCD and OCS were all associated with ele-
vated odds for having at least one mental disorder other
than OCD, when compared to the No OCS group.
Not only OCD, but also subthreshold OCD and OCS
were associated with elevated odds for substance abuse/
dependence, mood, anxiety disorders, and somatoform
disorders/syndromes when compared to the No OCS group.
In addition, OCD, subthreshold OCD and OCS were all
associated with increased odds of the presence of possible
psychotic disorder and bipolar disorder, compared to No
OCS.
Impairment and health-care utilization
The subjects in the OCD, subthreshold OCD and OCS
groups showed increased rates of impairment (Table 4),
with endorsements of 60.1, 19.9, and 21.1%, respectively.
The OCD, subthreshold OCD and OCS were associated
with elevated odds for impairment compared to the No
OCS group. Importantly, OCD and OCS were associated
with impairment even after adjusting for age, gender and
mental disorders other than OCD.
Considerable rates of health-care utilization were also
found in the OCD, subthreshold OCD and OCS groups,
with endorsement of having ever used health-care because
of mental problems in 68.2, 36.3, and 36.6%, respectively
(see Table 4). The OCD, subthreshold OCD and OCS were
again associated with elevated odds for health-care utili-
zation compared to No OCS. Finally, the association
between health-care utilization and OCS, but not OCD or
subthreshold OCD, remained significant when adjusting for
gender, age and mental disorders other than OCD.
Discussion
Using data from a representative population sample that
was assessed with a well-established standardized diag-
nostic interview, we examined the 12-month prevalence of
OCD, subthreshold OCD and OCS and their associations
with sociodemographic characteristics, comorbid other
mental disorders, current impairment, and health-care uti-
lization. Unlike previous research, we divided the sub-
threshold groups into two groups that varied by severity
(i.e., endorsing at least one symptom of obsessions or
compulsions vs. endorsing at least one symptom plus one
of the core DSM-IV criteria). By demonstrating the impact
of OCS, our results added important evidence to previous
research on subthreshold OCD. It has been argued that
OCD should be defined using less restrictive criteria
because subthreshold OCD might better describe the clin-
ical reality of individuals who suffer from this symptom-
atology [23, 52]. Our findings suggest that OCS without
further sub-clinical features is indeed clinically meaning-
ful, both in its own right and in the extremely common
presentation with comorbid conditions.
The 12-month prevalence of OCD found in this study
(0.7%) corresponds to previous studies conducted on the
general population, with ranges from 0.3 to 3.0% [2, 7, 9,
23, 31, 37, 50, 53, 57]. Twelve-month prevalence rates of
0.6 to 4.9% for subthreshold OCD that fulfill some but
not all the required DSM-IV criteria of threshold OCD
(4.5%) is likewise consistent with previous studies [3, 9,
22, 53]. In our effort to further scrutinize subthreshold OC
conditions, we examined OCS without further OCD fea-
tures and found a 12-month prevalence of 8.3%. It is
important to highlight that our OCS definition differed
from previous research on subthreshold OCS, as these
studies required the endorsement of further (sub) thresh-
old OCD features.
The overall 12-month prevalence of individuals who
report experiencing at least one OC symptom was 13.5% in
this representative sample. This is in accordance with the
OCS dimensions study by Fullana and colleagues [21]
(13%). However, our finding is considerably lower than the
prevalence of OCS examined in Switzerland (lifetime
29.8%) [14], in the USA (lifetime 28.2%) [50], and in
Canada (1-month 22.2–26.2%) [53], while it is higher than
the finding from the study by Nestadt and colleagues [40]
(1-month 1.5%) in the USA. Methodological differences
across the studies is likely to account for these varying
rates. Previous studies have utilized different diagnostic
criteria (i.e., DSM-III OCD criteria versus DSM-IV OCD),
time frames, instruments, and sampling methods. Accord-
ing to Fontenelle and colleagues [19] the majority of socio-
demographic features and core phenomenological symp-
toms of OCD were relatively independent of geographic,
ethnic and cultural differences across samples from Brazil,
North-, Latin America, Europe, Africa and Asia. Never-
theless, the interpretation of prevalence differences
between countries is difficult [5] because of the paucity of
studies that examine OCD across cultures [19].
We did not find gender differences regarding the
12-month prevalence rates of OCD, subthreshold OCD,
and OCS, which is supported by several studies [8, 9, 31],
but contradictory to some reports of gender differences in
the prevalence of subthreshold OCD [23] or OCS [14, 21].
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Consistent with the previous epidemiological and clin-
ical studies that reported decreased prevalence rates of
DSM-IV OCD in the elderly [8, 18, 37, 50, 57], our sub-
jects in the older age group (age: 50–65 years) showed a
lower prevalence rate of subthreshold OCD and OCS
compared to the younger age group (age: 18–34 years).
We were able to replicate previously reported strong
associations between OCD and substance abuse/depen-
dence [9, 50], mood [8, 10, 22, 31, 50, 57], anxiety [2, 8, 9,
22, 31, 50, 57] and somatoform disorders [22]. In addition,
we also found strong associations between subthreshold
OCD and these same disorders consistent with previous
Table 3 12-month prevalences of other DSM-IV disorders in OCD, subthreshold OCD and OCS (weighted data)
DSM-IV disorder OCD (n = 30) Subthreshold OCD
(n = 188)
OCS (n = 346) No OCS
(n = 3,617)
%
% OR 95% CI % OR 95% CI % OR 95% CI
Mental disorder due to general medical
condition
6.1 5.5*h (1.1–25.8) 1.6 1.5 (0.5–4.6) 3.3 3.1* (1.6–6.2) 1.1
Any substance abuse/dependencea 30.0 3.3* (1.5–7.3) 24.5 2.3* (1.5–3.5) 22.7 2.1* (1.6–2.9) 11.6
Alcohol abuse/dependence 14.1 6.3* (2.2–18.1) 11.3 4.1* (2.2–7.6) 9.8 3.5* (2.2–5.6) 3.1
Nicotine dependence 23.1 2.9* (1.2–6.8) 16.4 1.7* (1.1–2.8) 17.2 1.9* (1.4–2.7) 9.2
Any illicit substance abuse/dependence 1.9 2.7 h (0.3–21.0) 2.0 2.6 (0.7–8.9) 1.2 1.7 (0.6–4.9) 0.6
Possible psychotic disorderb 39.3 39.8* (18.7–84.8) 6.5 4.1* (2.1–8.3) 7.3 4.7* (2.9–8.0) 1.6
Any mood disorderc 69.0 21.3* (9.5–47.8) 29.6 4.0* (2.8–5.9) 23.8 3.0* (2.3–4.1) 9.4
Major depressive disorder 45.4 10.8* (5.2–22.2) 22.8 3.9* (2.6–5.9) 18.6 3.0* (2.2–4.3) 6.9
Dysthymic disorder 42.5 23.7* (11.2–50.2) 10.9 4.0* (2.3–7.0) 11.0 4.0* (2.7–6.0) 3.2
Any bipolar disorder 10.0 22.6* (6.3–80.9) 4.1 8.2* (3.4–19.7) 2.3 4.7* (2.0–11.2) 0.4
Any anxiety disorder other than OCDd 66.8 16.4* (7.4–36.2) 39.0 5.2* (3.7–7.4) 29.5 3.4* (2.6–4.6) 11.0
Panic disorder with/without agoraphobia 23.7 18.5* (8.0–42.9) 4.3 2.7* (1.3–5.7) 7.4 5.0* (3.0–8.4) 1.6
Agoraphobia without panic disorder 8.4 6.5* (1.8–24.1) 7.0 6.0* (3.2–11.3) 6.1 5.2* (3.1–8.8) 1.3
Panic attack 33.9 14.2* (6.4–31.3) 11.1 3.5* (2.2–5.9) 12.4 4.1* (2.7–6.1) 3.4
Social phobia 32.7 32.1* (13.9–74.1) 4.4 2.9* (1.3–6.7) 4.1 2.8* (1.6–5.1) 1.4
Any simple phobiae 28.8 5.9* (2.8–12.5) 23.4 4.7* (3.1–7.1) 15.1 2.7* (1.9–4.0) 5.9
Phobic disorder NOS 11.5 4.1* (1.4–12.3) 9.5 3.6* (2.0–6.4) 5.6 2.0* (1.2-3.4) 2.8
Generalized anxiety disorder 21.1 25.9* (10.7–62.8) 4.1 4.3* (1.9–9.9) 3.1 3.2* (1.6-6.4) 1.1
Any somatoform disorder/syndromef 51.8 10.4* (4.8–22.7) 20.4 2.5* (1.7–3.8) 20.7 2.6* (1.9-3.6) 9.3
SSI 4/6 12.4 3.7* (1.3–10.7) 9.3 2.8* (1.6–5.1) 7.7 2.3* (1.5-3.6) 3.7
Pain disorder 47.2 11.9* (5.4–26.5) 13.1 2.0* (1.2–3.2) 15.2 2.4* (1.7–3.5) 6.9
Hypochondriasis 0 – – 0.4 22.8*h (1.4–348.7) 0.3 16.1*h (1.04–249.7) 0.02
Any eating disorderg 1.7 6.2h (0.7–48.5) 0.5 1.6h (0.3–7.8) 1.2 4.3* (1.2–15.4) 0.2
Any of above 89.2 16.8* (5.1–55.9) 65.9 3.9* (2.8–5.7) 61.2 3.3* (2.5–4.3) 32.1
CI confidence intervals; DSM-IV Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; OCD obsessive–compulsive disorder;
OCS obsessive–compulsive symptoms; OR odds ratios from logistic regression adjusted for age and gender, ‘No OCS’ as a reference group
* p \ 0.05
a With nicotine dependence
b In the DIA-X/M-CIDI, possible psychotic disorder included the experience of psychotic symptoms of delusions or hallucinations combined
with speaking to a doctor about the symptoms
c Major depressive disorder, dysthymic disorder, bipolar I disorder, bipolar II disorder, single hypomanic episode
d Panic disorder with/without agoraphobia, agoraphobia without panic disorder, social phobia, any simple phobia, phobic disorder not otherwise
specified (NOS), generalized anxiety disorder
e Animal, natural environment, blood-injection-injury, situational type
f Somatization disorder, undifferentiated somatization disorder, somatic symptom index SSI 4/6 (according to Escobar et al. [16] four so-
matoform symptoms for males and six for females), pain disorder, hypochondriasis
g Anorexia nervosa, atypical anorexia nervosa (all DSM-IV criteria for anorexia are met except D or all are met except A, but BMI \18.5),
bulimia nervosa, atypical bulimia nervosa (all DSM-IV criteria for Bulimia met, except C criteria or except B criteria)
h These associations are based on a small number of comorbid cases (B2)
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research [2, 3, 9, 22]. Unlike most studies, however, we
additionally examined the association between OCS and
these disorders. Results suggest that the mere presence of
OCS is associated with increased odds for having sub-
stance, mood, anxiety, and somatoform disorders in the
subjects with OCS compared to subjects with No OCS.
Consistent with clinical studies that have documented
frequent comorbidity between OCD and bipolar disorders
[25, 33, 35, 42, 43], this sample revealed strong associa-
tions between bipolar disorders and OCD, subthreshold
OCD and OCS (ORs C 4.7). The association between
bipolar disorders and the varying definitions of OCD was
stronger than the association between the OCD definitions
and major depression. This is compatible with previous
reports that found a higher co-occurrence of OCD and
bipolar disorders than OCD and major depression in the
ECA study [6] and in the Zurich study [3].
Of special interest is our finding of the strong associa-
tion between possible psychotic disorder with OCD, sub-
threshold OCD and OCS groups (ORs C 4.1). Our finding
showed that 39.3% of the subjects with OCD, 6.5% of the
subjects with subthreshold OCD, and 7.3% of the subjects
with OCS met diagnostic criteria of possible psychotic
disorder. The frequent co-occurrence of OCD and psy-
chotic disorders are well documented in epidemiological
and clinical studies [4, 9, 16, 17, 27, 39, 41, 45, 46, 55];
and possible pathophysiological overlapping between OCD
and psychotic disorders has been suggested [24, 56].
Nevertheless, in a study by de Haan and colleagues [12]
psychotic disorders were present in only 1.7% of patients
with OCD, and De Haan and colleagues [13] suggested that
treatment of psychosis induces OCS or OCD in some
patients with a primary diagnosis of psychosis. Indeed,
using a prospective longitudinal design, de Haan and col-
leagues [11] found that severity of OCS was associated
with duration of antipsychotic treatment using olanzapine
in hospitalized young patients with psychosis. There is also
a case report in which OCS arose during the use of anti-
psychotic in a non-psychotic, bipolar patient [30]. On the
other hand, van Nimwegen and colleagues [58] demon-
strated a significant and clinically relevant decrease in the
presence of OCS with antipsychotic treatment in a 6-week,
randomized and double-blind multi-center study in young
in- and outpatients with psychosis. De Haan and colleagues
[11] suggested that genetic variation in patients with
schizophrenia might be related to increase or decrease in
OCS during antipsychotic treatment. Future epidemiolog-
ical and clinical studies should scrutinize the relationship
of these disorders in more detail.
Finally, our findings are consistent with previous studies
that found strong impairment and frequent use of health-
care in subjects with OCD [3, 23, 32, 50, 54, 57] and in
subjects with subthreshold OCD [2, 9, 23]. Moreover, we
additionally found that the presence of OCS alone has
considerable impact on impairment and health-care utili-
zation. Importantly, the associations between OCS and
impairment and health-care utilization remained signifi-
cant, even after adjusting for comorbid mental disorders.
The findings of this paper should be interpreted in light
of several limitations. First, although the GHS-MHS
examined a wide range of mental disorders, several dis-
orders that are supposed to be related to OCD were not
included, such as several OC spectrum disorders (e.g. body
dysmorphic disorder, pathologic grooming habits, and
impulse control disorders). Second, the GHS-MHS data are
based on the respondents’ self-reports and are based on
Table 4 Impairment and health-care utilization in OCD, subthreshold OCD and OCS (weighted data)
OCD (n = 30) Subthreshold OCD
(n = 188)
OCS (n = 346) No OCS
(n = 3,617)
%
% OR 95% CI % OR 95% CI % OR 95% CI
Impairmenta 60.1 19.9 21.1 7.2
Adjusted for gender and age 19.0* (9.0–40.2) 3.1* (2.0–4.7) 3.4* (2.5–4.6) OR = 1.0
Adjusted for gender, age and comorbid disordersb 3.8* (1.1–12.6) 1.4 (0.9–2.3) 1.9* (1.3–2.8) OR = 1.0
Health-care utilizationc 68.2 36.3 36.6 19.5
Adjusted for gender and age 8.8* (4.0–19.5) 2.4* (1.7–3.4) 2.4* (1.9–3.2) OR = 1.0
Adjusted for gender, age and comorbid disordersb 2.1 (0.8–5.4) 1.3 (0.9–2.0) 1.5* (1.1–2.1) OR = 1.0
CI confidence intervals; OCD obsessive–compulsive disorder; OCS obsessive–compulsive symptoms; OR odds ratios from logistic regression,
‘No OCS’ as a reference group
* p \ 0.05
a Based on the items of disability days (complete or partial) (yes/no)
b Comorbid disorders include mental disorder due to general medical condition, any substance abuse/dependence, possible psychotic disorder,
any mood disorder, any anxiety disorder other than OCD, any somatoform disorder/syndrome, any eating disorder
c Presented in form of a variable ‘at least minimal intervention’: a combination of questions for ‘‘Having ever sought any psychological or
psychiatric treatment due to mental problems or been recommended by a doctor to do so’’ (yes/no)
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their recollections; recall bias could have influenced in
some cases the accuracy of information (e.g. impairment,
health-care utilization). Third, health-care use was mea-
sured for lifetime, while diagnoses covered the previous
12 months. Fourth, as the number of subjects with DSM-IV
OCD was small (N = 38), some cells in the analyses of
comorbidity were very small.
In spite of these limitations, our findings suggest that
subjects not only with subthreshold OCD but also with only
OCS, both not currently captured by DSM-IV OCD crite-
ria, nevertheless show substantial comorbidity, impairment
and health-care utilization. This should be taken into
account in future conceptualization and classification of
OCD (DSM-V and ICD-11). Moreover, this may have
implications for clinical practice, in a way that even sub-
jects with OCS only may require attention. Finally, future
studies that focus on subjects with OCS only are highly
warranted to increase our understanding of this condition.
Taken together, the strong associations obtained in our
study between the presence of subthreshold OCD, OCS and
comorbidity, impairment, or health-care utilization suggest
that the presence of the full spectrum from OCS through
full diagnostic OCD has important implications for the
diagnosis, intervention, and quality of life of those affected.
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